(Q35496514)

8 August 2017

Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome (English)

1 reference

8 August 2017

1 reference

1 reference

James T McCracken

1

1 reference

8 August 2017

Robert Suddath

2

1 reference

8 August 2017

Susanna Chang

3

1 reference

8 August 2017

Sarika Thakur

4

1 reference

8 August 2017

John Piacentini

5

1 reference

8 August 2017

1 October 2008

1 reference

Journal of Child and Adolescent Psychopharmacology

8 August 2017

1 reference

8 August 2017

18

1 reference

8 August 2017

501-508

1 reference

8 August 2017

5

1 reference

Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Tourette syndrome: the self under siege

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Tourette's disorder: epidemiology and comorbidity in primary school children

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

A placebo-controlled trial of risperidone in Tourette syndrome

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Concurrent validity of the anxiety disorders section of the Anxiety Disorders Interview Schedule for DSM-IV: child and parent versions.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3205800

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18928414

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18928414

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1089/CAP.2007.135

1 reference

release_yqiltmlwozgcfjautyadclw5aa

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yqiltmlwozgcfjautyadclw5aa

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

3205800

1 reference

8 August 2017

1 reference